Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-06-14
2005-06-14
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S468000
Reexamination Certificate
active
06906093
ABSTRACT:
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
REFERENCES:
patent: 2872372 (1959-02-01), Hull
patent: 2968557 (1961-01-01), Burgandt et al.
patent: 4002749 (1977-01-01), Rovnyak
patent: 4053613 (1977-10-01), Rovnyak et al.
patent: 4642309 (1987-02-01), Michel et al.
patent: 4826847 (1989-05-01), Michel et al.
patent: 4853403 (1989-08-01), Shiraishi et al.
patent: 4868304 (1989-09-01), Larock et al.
patent: 4966849 (1990-10-01), Vallee et al.
patent: 4971996 (1990-11-01), Shiraishi et al.
patent: 5051417 (1991-09-01), Nadler et al.
patent: 5057538 (1991-10-01), Shiraishi et al.
patent: 5089516 (1992-02-01), Shiraishi et al.
patent: 5124347 (1992-06-01), Connor et al.
patent: 5196446 (1993-03-01), Levitzki
patent: 5202341 (1993-04-01), Shiraishi et al.
patent: 5206261 (1993-04-01), Kawaguchi et al.
patent: 5217999 (1993-06-01), Levitzki
patent: 5302606 (1994-04-01), Spada et al.
patent: 5322590 (1994-06-01), Koshimizu
patent: 5322950 (1994-06-01), Sircar et al.
patent: 5330992 (1994-07-01), Eissenstat et al.
patent: 5374652 (1994-12-01), Buzzetti et al.
patent: 5382593 (1995-01-01), Le Baut
patent: 5397787 (1995-03-01), Buzzetti et al.
patent: 5409903 (1995-04-01), Polak et al.
patent: 5409949 (1995-04-01), Buzzetti et al.
patent: 5463052 (1995-10-01), Haga et al.
patent: 5565324 (1996-10-01), Still et al.
patent: 5792783 (1998-08-01), Tang et al.
patent: 5880141 (1999-03-01), Tang et al.
patent: 5883113 (1999-03-01), Tang et al.
patent: 5883116 (1999-03-01), Tang et al.
patent: 5886020 (1999-03-01), Tang et al.
patent: 6313158 (2001-11-01), Tang et al.
patent: 6395734 (2002-05-01), Tang et al.
patent: 286870 (1964-12-01), None
patent: 2012634 (1991-09-01), None
patent: 876539 (1953-06-01), None
patent: 2159360 (1973-06-01), None
patent: 2159361 (1973-06-01), None
patent: 2159362 (1973-06-01), None
patent: 2159363 (1973-06-01), None
patent: 2321656 (1973-11-01), None
patent: 3310891 (1984-09-01), None
patent: 3426419 (1986-01-01), None
patent: 0351213 (1990-01-01), None
patent: 0 252 713 (1990-09-01), None
patent: 0566266 (1993-01-01), None
patent: 0525472 (1993-02-01), None
patent: 0580502 (1994-01-01), None
patent: 0632102 (1994-06-01), None
patent: 0626377 (1994-11-01), None
patent: 0 632 102 (1995-04-01), None
patent: 0662473 (1995-07-01), None
patent: 0788890 (1997-06-01), None
patent: WO 98 07695 (1998-02-01), None
patent: 1398224 (1965-03-01), None
patent: 2689397 (1993-10-01), None
patent: 809691 (1959-04-01), None
patent: 835473 (1960-05-01), None
patent: 6229570 (1987-02-01), None
patent: 6239564 (1987-02-01), None
patent: 63141955 (1988-06-01), None
patent: 558894 (1993-03-01), None
patent: 9286777 (1997-11-01), None
patent: 1384599 (1975-02-01), None
patent: 8807035 (1988-09-01), None
patent: 9115495 (1991-10-01), None
patent: 9221660 (1992-04-01), None
patent: 9203736 (1992-05-01), None
patent: 9207830 (1992-05-01), None
patent: 9113055 (1992-09-01), None
patent: 9301182 (1993-01-01), None
patent: 9403427 (1994-02-01), None
patent: 9410202 (1994-05-01), None
patent: 9414808 (1994-07-01), None
patent: 9501349 (1995-01-01), None
patent: 9514667 (1995-06-01), None
patent: 9517181 (1995-06-01), None
patent: 9600226 (1996-01-01), None
patent: 9616964 (1996-06-01), None
patent: 9622976 (1996-08-01), None
patent: WO 96/22976 (1996-08-01), None
patent: WO 96/32380 (1996-10-01), None
patent: WO 96/40116 (1996-12-01), None
patent: WO 97/25986 (1997-07-01), None
patent: 9725986 (1997-07-01), None
patent: 9736867 (1997-10-01), None
patent: WO 99/10325 (1999-03-01), None
U.S. Appl. No. 09/762,198 filed Feb. 5, 2001, Tang et al.
Desimoni et al., “Catalysis with Inorganic Cations. V.1Intramolecular Hetero Diels-Alder versus Ene Reactions: Effect of Magnesium Perchlorate on Chemoselectivity,”Tetrahedron,1996, pp. 1200-12018. vol. 52, No. 38, Elsevier Science Ltd.
Gibson et al., “Cleavage of Halogenobenzophenones by Potassamide in Ammonia; New Routes to Xanthem- and Thioxanthen-9-ones,”J.C.S. Perkin l, 1975, pp. 155-160.
Kulka et al., “t-Butyl as a Blocking Group in the Synthesis of o-Hydroxybenzophenones,” Nov. 5, 1954, pp. 5469-5471.
Howard, Provisional Appl. No. 60/015,134 filed Mar. 29, 1996 for “Lacam Derivatives”.
Abramovitch et al., “A Novel Synthesis of a Cyclic Hydroxamic Acid Involving a Molecular Rearrangement,”Chemistry and Industry44:1871 (1967).
Abramovitch and Hey, “Internuclear cyclisation,”J. Chem. Soc.pp. 1697-1703 (1954).
Akbasak and Sunar-Akbasak et al., “Oncogenes: cause or consequence is the development of glial tumors,”J. Neurol. Sci.111:119-133 (1992).
Andreani et al., “Synthesis and cardiotonic activity of 2-indolinomes,”Eur. J. Med. Chem, 25:187-190 (1990).
Andreani et al., “Synthesis and cardiotonic activity of 2-Indolinomes bearing pyridyl groups,” Eur. J. Med. Chem. 28:653-657 (1993).
Andreani et al., “Synthesis of lacatams with potential cardiotonic activity,”Eur. J. Med. Chem.28:825-829 (1993).
Andreani et al., “Synthesis and cardiotonic activity of pyridylmethylene-2-indolinones,”Eur. J. Med. Chem,27:167-170 (1992).
Arteaga et al., “Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice,”J. Clin. Invest,84:1418-1423 (1989).
Audrey and Tahk, “The Synthesis and Sterochemistry of Some Isatylideneacetic Acid Derivatives,”Tetrahedron23:901-917(1967).
Bahner et al., “Benzylideneindenes with Oxygen Attached to the Indene Ring,”J. Med. Chem.12:721-722 (1969).
Bamfield et al., “Diels-Alder Reactions of Oxindolylideneacetone,”J. Chem. Soc.(C) pp. 1028-1030 (1966).
Baserga, “Oncogenes and the strategy of growth factors,”Cell79:927-930 (1994).
Baserga, “The Insulin-like growth factor I receptor: a key to tumor growth”Cancer Res, 55:249-252 (1995).
Blake and Jaques, “Anisotropic Effects In alpha-substituted methoxystilbenes,”J. Chem. Soc. Perkin IIpp. 1660-1663 (1973).
Bolen et al., “The Src family of tyrosine protein kinases in hemopoietic signal transduction,”FASEB J.6:3403-3409 (1992).
Bolen, “Nonreceptor tyrosine protein kinases,”Oncogene8:2023-2031 (1993).
Borsche et al., “Uber nielkernige kondersierte systeme mit heterocyclischen ringen,”Liebigs Ann. Chem,550:160-174 (1941).
Buzzetti et al., “Cinnamamide Analogs as Inhibitors of Protein Tyrosine Kinases,”II Farmaco48:615-636 (1993).
Canoira and Rodriguez, “Synthesis of Oxindole Derivatives from N-Alkenyl-o-Chloroanilides with Zero-Valent Nickel Complex,”J. Heterocyclic Chem,22:1511-1518 (1985).
Chatten et al., “Substituted Oxindoles. Part VI. Polargraphic Reduction of Substituted trans-3-benzylideneindol-2(3H)-ones,”J. Chem. Soc. Perkin IIpp. 469-473 (1973).
Coda et al., “(Z)- and (E)-Arylidene-1,3-dihydroindol-2-ones: Configuration, Conformation and Infrared Carbonyl Stretching Frequencies,”J. Chem. Soc. Perkin IIpp. 615-619 (1984).
Coppola et al., “A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor,”Mol. Cell. Biol.14:4588-4595 (1994).
Daisley, “Thin-layer Chromatographic separation of some substituted 3-benzylidine-indol-2(3H)-ones,”J. Chromatography100:240-242 (1974).
Dati et al., “Inhibition of c-erB-2 oncogene expression by estrogen in human breast cancer cells,”Oncogene5:1001-1006 (1990).
De Vries et al., “The fms-Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor,”Science255:989-991 (1992).
Decker and Lohmann-Matthes, “A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity,”L. Immun
Hirth Klaus Peter
McMahon Gerald
Shawver Laura Kay
Sun Li
Tang Peng Cho
Burrous Beth A.
Foley & Lardner LLP
McKane Joseph K.
Saeed Kamal
Sugen Inc.
LandOfFree
Indolinone combinatorial libraries and related products and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indolinone combinatorial libraries and related products and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indolinone combinatorial libraries and related products and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3465502